Long-term increase in CD4+ T-cell counts during combination antiretroviral therapy for HIV-1 infection - Test2 - elhamkhani - TriplyDB

Long-term increase in CD4+ T-cell counts during combination antiretroviral therapy for HIV-1 infection

Long-term increase in CD4+ T-cell counts during combination antiretroviral therapy for HIV-1 infection

http://www.wikidata.org/entity/Q34477711

about

Long-Term Survival of AIDS Patients Treated with Only Traditional Chinese Medicine.Combined models for pre- and post-treatment longitudinal biomarker data: an application to CD4 counts in HIV-patients.Biochemical and haematological changes in HIV subjects receiving winniecure antiretroviral drug in Nigeria A decade of HAART in Latin America: Long term outcomes among the first wave of HIV patients to receive combination therapy.CD4 trajectory adjusting for dropout among HIV-positive patients receiving combination antiretroviral therapy in an East African HIV care centre.A South African public-private partnership HIV treatment model: viability and success factors.Factors associated with remaining on initial randomized efavirenz-containing regimens.Long-term CD4+ lymphocyte response following HAART initiation in a U.S. Military prospective cohort.Progress realized: trends in HIV-1 viral load and CD4 cell count in a tertiary-care center from 1999 through 2011 Life expectancies of South African adults starting antiretroviral treatment: collaborative analysis of cohort studies.Among patients with sustained viral suppression in a resource-limited setting, CD4 gains are continuous although gender-based differences occur.Long-term CD4+ cell count in response to combination antiretroviral therapy.Repeated assessments of food security predict CD4 change in the setting of antiretroviral therapy.Incidence rate of and factors associated with loss to follow-up in a longitudinal cohort of antiretroviral-treated HIV-infected persons: an AIDS Clinical Trials Group (ACTG) Longitudinal Linked Randomized Trials (ALLRT) analysis.CD4 Response Up to 5 Years After Combination Antiretroviral Therapy in Human Immunodeficiency Virus-Infected Patients in Latin America and the Caribbean.HIV RNA suppression and immune restoration: can we do better?Impact of Age and Sex on CD4+ Cell Count Trajectories following Treatment Initiation: An Analysis of the Tanzanian HIV Treatment Database.U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008.Impact of time to start treatment following infection with application to initiating HAART in HIV-positive patients.Efficacy of a clinical decision-support system in an HIV practice: a randomized trial.Poor immunological recovery among severely immunosuppressed antiretroviral therapy-naïve Ugandans.The Significance of Interferon-γ in HIV-1 Pathogenesis, Therapy, and Prophylaxis.The impact of age on the prognostic capacity of CD8+ T-cell activation during suppressive antiretroviral therapy.Three different patterns of CD4 recovery in a cohort of Chinese HIV patients following antiretroviral therapy - a five-year observational study.Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy Long-term trends in CD4 cell counts and impact of viral failure in individuals starting antiretroviral therapy: UK Collaborative HIV Cohort (CHIC) study.Patients' perceptions of a rural decentralised anti-retroviral therapy management and its impact on direct out-of-pocket spending.Latently infected cell activation: a way to reduce the size of the HIV reservoir?Predictors of CD4 cell recovery following initiation of antiretroviral therapy among HIV-1 positive patients with well-estimated dates of seroconversion.Lessons Learned from Protective Immune Responses to Optimize Vaccines against Cryptosporidiosis.Long-term clinical, immunological and virological outcomes of patients on antiretroviral therapy in southern Myanmar.Virologic failure and mortality in older ART initiators in a multisite Latin American and Caribbean Cohort.Stroke incidence is highest in women and non-Hispanic Blacks living with HIV in the ALLRT cohort.Virological and immunological failure of HAART and associated risk factors among adults and adolescents in the Tigray region of Northern Ethiopia.

P2860

Q30151479-A124DB9A-18BE-417B-8927-8175DFEB1448 Q31131058-BD81E38B-F680-4A38-B1EA-A9F2469F9856 Q33410774-A420FA33-1132-4610-BB05-1CCE830A07A6 Q33834625-4B1CE90E-ED22-46C1-BCD9-80FE6428FD1B Q34059861-532E5A3F-8B8F-49BA-8F4A-E18AA63920D0 Q34374299-AC142DFF-238A-4824-9075-B5B21EEDB493 Q34378368-B3A82795-8C85-4B0A-A70E-F42005538437 Q34569335-CA5EDD2B-A700-4224-AABE-1AC87804436D Q34599593-ACA57B9A-2687-4D6F-B5FF-AA9D696ADE2A Q34667707-23424FE7-0EC6-4D37-9FA6-1FBDFF3ACA41 Q34981015-732C7AA1-4032-48C5-9A81-E7FE86F03C52 Q35138526-D071986F-5207-4D0B-92C7-8C5DF0EFE729 Q35175836-C69545F9-73F5-45FC-A757-08047B5AD011 Q35513989-68EB8BBB-D31E-45AC-942E-2CACBFA3578E Q35837756-DB57B3DF-34EB-458B-B177-81CCF07B0AB0 Q35867173-B41C62A7-0A8F-4F41-8C27-F6FC351B2E27 Q36157659-DAF49E5F-1617-4BAF-B0CA-2EC91E99084E Q36501102-8A088606-6FA3-47CA-AE46-CDE20CC76FBE Q37263116-223E0327-3EF3-49F5-99A4-AD3732E55952 Q37313077-0D774FFA-D9EE-45C7-81CB-7654B320AE71 Q37378374-A701C75F-7DC3-487A-9FD6-B464A21DE2F8 Q37466832-69F7AE76-53AD-4299-8788-2FBF5A162D56 Q37600137-062FB14C-C974-4FF1-AF90-A6F692591147 Q41716615-78B5E9CC-05A1-4A25-ACC9-27B8C004734F Q42720721-17A4FC46-732E-4631-B9A9-A1C134654FBD Q44256226-1CA5CE3D-659C-4E87-8685-BBABDCA357F5 Q47147768-9AB64D53-5E25-4063-A687-E0A445918B06 Q47311740-D85B46F9-5664-40BA-807C-6689E256ADEB Q47325438-1D5972E7-A1A2-42EF-AAF1-DD2153BEA5B6 Q47733620-B7ECE098-4511-458D-9ACA-0D24E8976022 Q50053558-D22192EE-F5D2-4F0D-9056-96A4AA5ACA33 Q51760332-36F7CE70-388D-4525-ADDF-B4E542913FF4 Q52652300-6F52C8D2-DA1F-4282-AD78-C1BB53F48897 Q55519161-42830D97-7E51-48C1-B2C5-34B3A9A6456C

P2860

Long-term increase in CD4+ T-cell counts during combination antiretroviral therapy for HIV-1 infection

http://www.wikidata.org/entity/Q34477711

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Long-term increase in CD4+ T-c ...... al therapy for HIV-1 infection

@ast

Long-term increase in CD4+ T-c ...... al therapy for HIV-1 infection

@en

Long-term increase in CD4+ T-c ...... al therapy for HIV-1 infection

@nl

type

label

Long-term increase in CD4+ T-c ...... al therapy for HIV-1 infection

@ast

Long-term increase in CD4+ T-c ...... al therapy for HIV-1 infection

@en

Long-term increase in CD4+ T-c ...... al therapy for HIV-1 infection

@nl

prefLabel

Long-term increase in CD4+ T-c ...... al therapy for HIV-1 infection

@ast

Long-term increase in CD4+ T-c ...... al therapy for HIV-1 infection

@en

Long-term increase in CD4+ T-c ...... al therapy for HIV-1 infection

@nl

P1433

Q34477711-2C7DD2C4-3D24-433D-897D-14D11B8C738A

P1476

Q34477711-066F8DE0-932B-4219-B942-5FC343213FB0

P2093

Q34477711-3A71A809-A6B4-4DF8-B147-C0083E845DBD

Q34477711-5FCC94C3-F7C5-4672-9E92-4D63D7458A4D

Q34477711-79957B6E-3BAE-43E9-A128-4F8271FAF49B

Q34477711-7AD96A92-B8D6-478E-ABA7-23796BD5C2D2

Q34477711-AA555265-8F7A-473D-8E33-0901FE817EFF

Q34477711-B5C1DB2F-7E26-4F13-B147-60567DE700B9

Q34477711-DC973A90-147D-40A4-84FF-F81F5DBB9D59

Q34477711-FAC84C9C-1090-42D6-85BA-5E35CB99BCB9

P2860

Q34477711-0FC32A66-CAE1-4106-B6AD-863E71C5744B

Q34477711-116E8662-DBE3-4191-A8D6-DD6512D6267F

Q34477711-14E78DD0-770B-43F6-AB9A-3EF04BC586E3

Q34477711-24BBE5A6-CBD6-4056-91F2-42EC9F7B1B61

Q34477711-251FA1D0-8BAD-4630-9AA5-40EBFC9A5D41

Q34477711-3A8E04E3-6748-4D7E-B86E-908D3EB096F4

Q34477711-3AC8E3DC-3472-41DC-B6C5-12A1327CD99E

Q34477711-4EF4FF37-6718-4499-A0BF-F656730A131E

Q34477711-5BFF153C-A89C-48EA-804F-F280FD6C023F

Q34477711-6A65BD09-E7FD-4360-A3D5-47FEF285500F

P304

Q34477711-177F10F3-B8F3-4B26-9793-8DCFCD98C6D4

P31

Q34477711-E909516B-3A38-4DEA-AC25-77AC43F12080

P356

Q34477711-CA781B3E-60A1-466C-8DD8-2E0DBEB6F884

P407

Q34477711-BCAA1759-9361-4636-AE14-D847FA87D14B

P433

Q34477711-9A6F1A22-F9AA-4B49-B473-C1B334E48D78

P478

Q34477711-83898B0B-FCE1-4886-8041-CB3A0D3D35BD

P577

Q34477711-8B604A64-4CD4-42E1-88CA-DD7C3B4F1162

P698

Q34477711-F62FFE08-0A4C-48FF-8285-FC84E7FF0ABC

P921

Q34477711-13B9E7C6-5FF5-4E9B-AC50-CBE8541A4E47

P932

Q34477711-8F6A9839-3054-40E1-AF31-BEE4AADEAD2A

P356

QAD.0B013E32833ADBCF

P1433

P1476

Long-term increase in CD4+ T-c ...... al therapy for HIV-1 infection

@en

P2093

ALLRT team

http://www.w3.org/2001/XMLSchema#string

Ann C Collier

http://www.w3.org/2001/XMLSchema#string

Constance A Benson

http://www.w3.org/2001/XMLSchema#string

Gregory K Robbins

http://www.w3.org/2001/XMLSchema#string

Judith J Lok

http://www.w3.org/2001/XMLSchema#string

Michael D Hughes

http://www.w3.org/2001/XMLSchema#string

Robert W Shafer

http://www.w3.org/2001/XMLSchema#string

Ronald J Bosch

http://www.w3.org/2001/XMLSchema#string

P2860

Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies

CD4+ count-guided interruption of antiretroviral treatment

The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals

Effect of early versus deferred antiretroviral therapy for HIV on survival.

Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study.

Long-term CD4+ T-cell response to highly active antiretroviral therapy according to baseline CD4+ T-cell count.

Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study.

HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies.

Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment.

Comparison of dynamic treatment regimes via inverse probability weighting.

P304

1867-1876

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/QAD.0B013E32833ADBCF

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P577

2010-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20467286

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

3018341

http://www.w3.org/2001/XMLSchema#string